T1	Participants 113 171	operable breast cancer with 0 to 3 positive axillary nodes
T2	Participants 405 429	metastatic breast cancer
T3	Participants 546 568	perable breast cancer.
T4	Participants 590 737	Women with invasive breast cancer were eligible if there were one to three positive lymph nodes or if the node-negative tumor was greater than 1 cm
T5	Participants 1074 1106	2,882 eligible patients enrolled
